Novartis Ag (NVS) Gross Profit (2009 - 2025)

Novartis Ag (NVS) has 15 years of Gross Profit data on file, last reported at $11.5 billion in Q2 2025.

• Quarterly Gross Profit rose 18.71% year-over-year to $11.5 billion in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $56.4 billion (down 98.88% YoY) and the FY2025 annual result came in at $43.0 billion, up 10.49% from the prior year.
• Gross Profit slipped to $11.5 billion in Q2 2025 per NVS's latest filing, from $18.7 billion in the prior quarter.
• The five-year high for Gross Profit was $34000.0 billion in Q1 2022, with the low at -$1000.0 billion in Q4 2022.
• Average Gross Profit over 5 years is $2791.7 billion, with a median of $9.5 billion recorded in 2021.
• The widest YoY moves for Gross Profit: up 242857042.86% in 2022, down 7142957.14% in 2022.
• Novartis Ag's Gross Profit stood at $14.0 million in 2021, then slumped by 7142957.14% to -$1000.0 billion in 2022, then jumped by 101.65% to $16.5 billion in 2023, then advanced by 13.76% to $18.7 billion in 2024, then plunged by 38.5% to $11.5 billion in 2025.
• Business Quant data shows NVS's Gross Profit at $11.5 billion in Q2 2025, $18.7 billion in Q4 2024, and $9.7 billion in Q2 2024.